Improved survival and nephroprotection in hypertensive rats by BAY 94-8862, a novel non-steroidal mineralocorticoid receptor antagonist

被引:0
|
作者
Kolkhof, P. [1 ]
Kretschmer, A. [2 ]
Baerfacker, L. [3 ]
Hartmann, E. [4 ]
Schaefer, S. [1 ]
机构
[1] BAYER HealthCare, Global Drug Discovery, Cardiol Res, Wuppertal, Germany
[2] BAYER HealthCare, Global Drug Discovery, Target Discovery, Wuppertal, Germany
[3] BAYER HealthCare, Global Drug Discovery, Med Chem, Wuppertal, Germany
[4] BAYER HealthCare, Inst Toxicol, Wuppertal, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:978 / 979
页数:2
相关论文
共 50 条
  • [1] Cardiorenal protection by BAY 94-8862, a novel non-steroidal mineralocorticoid receptor antagonist in a preclinical model of hypertension and diastolic heart failure
    Delbeck, M.
    Kretschmer, A.
    Kast, R.
    Baerfacker, L.
    Hartmann, E.
    Schaefer, S.
    Kolkhof, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 772 - 773
  • [2] Pronounced cardiac protection by BAY 94-8862, a novel non-steroidal mineralocorticoid receptor antagonist in a preclinical rat model of heart failure
    Albrecht-Kuepper, B.
    Kretschmer, A.
    Kast, R.
    Baerfacker, L.
    Schaefer, S.
    Kolkhof, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 7 - 7
  • [3] Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
    Baerfacker, Lars
    Kuhl, Alexander
    Hillisch, Alexander
    Grosser, Rolf
    Figueroa-Perez, Santiago
    Heckroth, Heike
    Nitsche, Adam
    Ergueden, Jens-Kerim
    Gielen-Haertwig, Heike
    Schlemmer, Karl-Heinz
    Mittendorf, Joachim
    Paulsen, Holger
    Platzek, Johannes
    Kolkhof, Peter
    CHEMMEDCHEM, 2012, 7 (08) : 1385 - 1403
  • [4] Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment
    Heinig, Roland
    Kimmeskamp-Kirschbaum, Nina
    Halabi, Atef
    Lentini, Silvia
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (06): : 488 - 501
  • [5] Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment
    Heinig, Roland
    Lambelet, Marc
    Nagelschmitz, Johannes
    Alatrach, Abir
    Halabi, Atef
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (05) : 619 - 628
  • [6] Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment
    Roland Heinig
    Marc Lambelet
    Johannes Nagelschmitz
    Abir Alatrach
    Atef Halabi
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 619 - 628
  • [7] Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
    Pitt, Bertram
    Kober, Lars
    Ponikowski, Piotr
    Gheorghiade, Mihai
    Filippatos, Gerasimos
    Krum, Henry
    Nowack, Christina
    Kolkhof, Peter
    Kim, So-Young
    Zannad, Faiez
    EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2453 - 2463
  • [8] SUPPRESSION OF MOUSE CRESCENTIC GLOMERULONEPHRITIS WITH A NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONIST
    Tesch, G. H.
    Han, Y.
    Ma, F.
    Nikolic-Paterson, D. J.
    Kolkhof, P.
    NEPHROLOGY, 2015, 20 : 33 - 34
  • [9] CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
    Arai, Kiyoshi
    Tsuruoka, Hiroyuki
    Homma, Tsuyoshi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 : 266 - 273
  • [10] Pharmacokinetics, distribution, and disposition of esaxerenone, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist, in rats and monkeys
    Yamada, Makiko
    Takei, Makoto
    Suzuki, Eiko
    Takakusa, Hideo
    Kotsuma, Masakatsu
    Washio, Takuo
    Murayama, Nobuyuki
    Inoue, Shin-ichi
    Izumi, Takashi
    XENOBIOTICA, 2017, 47 (12) : 1090 - 1103